Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Voice of the patient: Emergence of new motor and non-motor symptoms in early Parkinson’s Disease?

View ORCID ProfileMichelle H.S. Tosin, View ORCID ProfileTanya Simuni, View ORCID ProfileGlenn T. Stebbins, View ORCID ProfileJesse M. Cedarbaum
doi: https://doi.org/10.1101/2021.06.21.21258883
Michelle H.S. Tosin
1Department of Nursing, Fluminense Federal University, Niterói, RJ, BRA
2Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michelle H.S. Tosin
Tanya Simuni
3Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tanya Simuni
Glenn T. Stebbins
2Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Glenn T. Stebbins
Jesse M. Cedarbaum
4Coeruleus Clinical Sciences LLC, Woodbridge CT, USA
5Department of Neurology, Yale University School of Medicine, New Haven, CT, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jesse M. Cedarbaum
  • For correspondence: jesse.cedarbaum@yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To explore the utility of using patient reported emergence of new symptoms (ES) as an outcome measure during the early phase of the disease.

Methods We analyzed data from MDS-UPDRS Part IB and Part II from the Safety, Tolerability, and Efficacy Assessment of Isradipine for PD (STEADY-PD3) study, with at least one annual follow-up over two years. We divided the sample into categories of follow-up visit (between 0 and 12-months, and 13 and 24-months) and the number of ES for each part of the scale between participants who started symptomatic treatment and those who did not (STx-yes/no). We assessed ES differences between participants STx in each follow-up visit using Mann-Whitney U test, and the Kaplan-Meier analyses.

Results Of 331 participants observed for months 0 to 12, 288 (87%) developed ES, and 182 (55%) started STx. For Part IB, the median number of ES did not significantly differ between the STx groups (Z=-0.86, p = 0.39), while for Part 2, the number of ES was significantly higher for the STx-yes group (Z=-2.38, p=0.02). Of 148 participants who continued to be observed for months 13 to 24, 114 (77%) developed ES, and 62 (42%) started STx. For Part IB, the median number of ES did not significantly differ between the STx groups (Z=-0.33, p = 0.74), while for Part 2, the number of ES was significantly higher for the STx-yes group (Z=-2.25, p=0.02).

Conclusions Assessing ES among patient-reported experiences of daily living may provide a useful marker for tracking PD progression.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT02168842

Funding Statement

The authors recieved no third party support for this work

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of Rochester IRB: https://www.rochester.edu/ohsp/rsrb/

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Financial Disclosure/Conflict of Interest concerning the research related to the manuscript and Funding sources for study: none

Data Availability

Data are available on NINDS clinical trials repository Archived Clinical Research Datasets | National Institute of Neurological Disorders and Stroke (nih.gov) https://c-path.org/programs/cpp/ https://amp-pd.org/whole-genome-data

https://www.ninds.nih.gov/sites/default/files/sig_form_revised_508c.pdf

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 24, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Voice of the patient: Emergence of new motor and non-motor symptoms in early Parkinson’s Disease?
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Voice of the patient: Emergence of new motor and non-motor symptoms in early Parkinson’s Disease?
Michelle H.S. Tosin, Tanya Simuni, Glenn T. Stebbins, Jesse M. Cedarbaum
medRxiv 2021.06.21.21258883; doi: https://doi.org/10.1101/2021.06.21.21258883
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Voice of the patient: Emergence of new motor and non-motor symptoms in early Parkinson’s Disease?
Michelle H.S. Tosin, Tanya Simuni, Glenn T. Stebbins, Jesse M. Cedarbaum
medRxiv 2021.06.21.21258883; doi: https://doi.org/10.1101/2021.06.21.21258883

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9772)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1561)
  • Health Policy (736)
  • Health Systems and Quality Improvement (603)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11649)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4661)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)